The Southeast Asian Breast Cancer Symposium

Prof. Pham Nhu Hiep

Professor Hiep graduated as a general physician from Hue Medical University in 1989 and became a resident doctor in France in 1998. After completing a PhD in 1996, he obtained a Specialist Level 2 degree in 2001. He was a member of the Standing Committee of the Vietnam Cancer Society from 2014 to 2021, vice president of the Vietnam Cancer Society from 2022 to now, and president of the Hue Cancer Society from 2015 to now. He is an expert in surgery, particularly oncology and laparoscopy. He is one of the experts in Vietnam who conducts training courses on Laparoscopy for many doctors in Vietnam as well as other countries: USA, Germany, France, Japan, Singapore, ... In addition to serving as the director of Hue Central Hospital and the Hue Oncology Center, Professor is also chairman of the Professional Council for Health Protection of Central Officials in central Vietnam, vice president of the Vietnam Society of Hepatobiliary, vice president of the Vietnam Surgical Society, a member of The State Council for Professors of Viet Nam, and a member of the American Society of Clinical Oncology (ASCO). From 1991 until 2022, he published more than 100 scientific articles, mostly on oncology and laparoscopy, in Vietnam and internationally.

Carolyn Taylor

Carolyn Taylor is a supportive cancer care advocate and a survivor of ovarian and endometrial cancers. In 2011, she founded and is Executive Director of Global Focus on Cancer (GFC) Carolyn leverages her networking skills to build broad-based partnerships and alliances to introduce culturally relevant, evidence-based, cancer awareness and supportive initiatives across resource settings. She serves as a content expert with the Women’s Empowerment Cancer Advocacy Network, sits on ASCO’s Gynecologic Cancer Guidelines Committee and a Measures Panel’ and is a member of the Lancet Commission on Women and Cancer.

PGS. TS Tran Thanh Huong

Assoc. Prof. Dr. Tran Thanh Huong graduated from Hanoi Medical University in 1996 and obtained her Ph.D. in Social Medicine and Medical Psychology from the Karolinska Institute in Sweden in 2006. Currently, Assoc. Prof. Dr. Huong holds several important positions, including being the Director of the National Cancer Institute, Head of the International Cooperation and Scientific Research Department at K Hospital, and the Head of the Department of Medicine & Psychology at Hanoi Medical University. She also serves as the Director of the Cancer Patient Support Fund - Bright Furture. Dr. Huong has been actively involved in various training programs and research related to cancer risk factors and non-communicable diseases. She is the Project Coordinator for the collaborative project between the National Cancer Institute of Vietnam and Vanderbilt University, ""Building a plan for the development of a deep cancer and non-communicable diseases research center in the region."" Additionally, she is involved in other projects such as ""Communication campaign & early detection screening for breast cancer - For women, for tomorrow"" and ""Social support for cancer patients."" Assoc. Prof. Dr. Huong has published numerous scientific papers in reputable national and international journals.

Professor Benjamin Olney Anderson

Dr. Anderson is a Surgery and Global Health Medicine Professor at the University of Washington (UW). As surgical director of the UW Breast Health Clinic, Dr. Anderson cared for patients with breast health issues and diseases from 1994-2020. He served as president of the American Society of Breast Disease (ASBD) from 2005–07 and vice chair of the National Comprehensive Cancer Network (NCCN) Breast Panel from 2013-20. Dr. Anderson has worked internationally in global cancer control for over 25 years. With joint appointments at the Fred Hutchinson Cancer Research Center Division of Public Health Sciences and the UW Department of Global Health, Dr. Anderson chaired the Breast Health Global Initiative (BHGI), which pioneered the development of “resource stratified” guidelines in low- and middle-income countries. Dr. Anderson served on the Board of Directors of the Union for International Cancer Control (UICC) from 2012 - 2018. He received the 2011 Partners in Progress Award from the American Society of Clinical Oncology (ASCO), the 2013 Inspiration Award from the National Consortium of Breast Centers (NCBC), the 2019 Pioneers of Global Health Award from the Washington Global Health Alliance (WGHA) and the 2023 Umberto Veronesi Memorial Award from the European School of Oncology (ESO). In 2020, Dr. Anderson joined the World Health Organization (WHO) and now serves as WHO Medical Officer leading the Global Breast Cancer Initiative (GBCI) launched in March 2021

Professor. Olufunmilayo Olopade

Funmi Olopade, M.D., F.A.C.P., O.O.N., is the Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics and founding director of the Center for Clinical Cancer Genetics and Global Health at The University of Chicago Medicine. Dr. Olopade’s research is focused on gaining a better understanding of the root causes and genomic basis of cancer in diverse populations. She has published extensively on genetics and non-genetic risk factors for breast cancer and is internationally renowned for her seminal work in inherited cancer syndromes and clinical expertise in early detection and prevention of breast cancer in high-risk women. Dr. Olopade mapped genes frequently altered in cancer and has characterized the molecular pathways defining aggressive forms of breast cancer in women of African ancestry. A distinguished scholar and mentor, Olopade has been elected to the most prestigious academies and societies including the National Academy of Science, National Academy of Medicine, the American Academy of Arts and Sciences and the American Philosophical Society to mention a few. Olopade served for six years as a member of the National Cancer Advisory Board and Chair of the Sub-Committee on Global Cancer Research under the Obama Administration. Olopade has received numerous honors and awards including honorary degrees from several universities, Franklin Roosevelt Freedom from Want Medal, The Order of Lincoln, Officer of the Order of the Niger and a 2005 MacArthur Fellowship for “translating findings on the molecular genetics of breast cancer in African and African-American women into innovative clinical practices in the United States and abroad.” Dr. Olopade earned her medical degree from the University of Ibadan College of Medicine in Nigeria. She trained in Internal Medicine at Cook County Hospital in Chicago and in combined Hematology/Oncology and Cancer Genetics at the Joint Section of Hematology and Oncology at the University of Chicago. An advocate for social justice, she serves as director on several Civic and Corporate Boards in Chicago.

Ms. Alyssa A. Grissom

Alyssa Grissom is an Oncology Clinical Nurse Specialist who has served many roles in the oncology field over the last 15 years. As a staff nurse then advanced practice nurse, Alyssa has always valued providing her patients with the education needed to promote self-care and informed decision making. Now that passion has transcended beyond patient care to empower nurses in the US and Vietnam to develop their knowledge and career in oncology. Throughout Alyssa’s career and more notably the last 3 years in Vietnam, her work consists of mentoring and staff professional development, developing and implementing oncology nurse training programs, publications, global conference presentations, and partnering with 2 medical volunteer organizations. Her contributions to oncology care have been recognized, as Alyssa received in 2022, the ONCC Advanced Oncology Nurse of the Year Award and 40 under 40 in cancer care.

ThS. BS. Nguyen Ba Tinh

Mr. Nguyen Ba Tinh completed his general doctor at Thai Binh Medical University in 2007, after which he enrolled in the Master of Public Health program at Hanoi Medical University in 2006. He assumed the position of Vietnam Young Physicians Association Vice President and General Secretary from 2011 to 2017. He is currently the Vice- Director of Supportive Fund for the Cancer Patients – Bright Future.and the Head of the Social Work Department. He is the one who develops numerous concepts and models for the Hospital's social work, with a focus on underprivileged individuals and cancer patients.

Professor. Yeol Kim, MD, MPH, PhD

Prof. Yeol Kim is a family physician and an expert on cancer screening and cancer survivorship in National Cancer Center of South Korea (KNCC). Prof. Kim has taught cancer survivorship in NCC- Graduate school of Cancer Science and Policy (GCSP). He is the head of Division of Public Health and Social Support in KNCC now. He has been working for not only caring for cancer survivors as a clinician but also making efforts for supporting cancer survivors to live well in the community. He established the Re:Born center for supporting job return and social rehabilitation for cancer survivors. Also, he is famous as the principal investigator of Korean Lung Cancer Screening Project (K-LUCAS) to implement national lung cancer screening program in Korea.

ANNA CABANES Ph.D., M.P.H.

Healthcare executive, with demonstrated leadership and achievements in public health at both local and international levels, and experience in leading change, operational know-how, effective management, building trust and collaborations, and developing and maintaining partner relations. Global health expert and cancer control advocate with expertise in health system strengthening, data analysis, and scalable care delivery models; in the development of policies and strategies; and community mobilization, dissemination of information, and capacity building. Has directed cancer programs in North and South America and Africa, worked in cancer in more than 25 countries, traveled to 65+, and lived in Europe, the Middle East, and the USA. Speaks 3 languages fluently, and 2 others at a basic level. Leverages strong leadership and management skills to forge highly productive and efficient teams.

Professor. Boguslawa (Bogda) Koczwara

Professor Koczwara is a senior staff specialist in medical oncology at the Flinders Medical Centre in Adelaide, Australia and she leads the Survivorship Research Program at the Flinders University Health and Medical Research Institute. Professor Koczwara established one of the first cancer survivorship programs in Australia and has contributed to key advancers in the field including survivorship epidemiology, self-management support, and the use of patient reported outcomes in cancer. She chairs the Multinational Association of Supportive Care in Cancer Psychosocial Study Group, the International Cardio Oncology Society Survivorship Working Group and is the convenor of the Global Partnership on Self-management in Cancer. She co-chairs the joint Clinical Oncology Society of Australia and Cardiac Society of Australia and New Zealand Cardio-Oncology Working Group and leads a national Working Group on implementation of patient reported outcomes in cancer. She is the initiator of the Australia Asia Pacific Clinical Oncology Research Development, a collaborative of international cancer organizations aimed at improving cancer research capacity in Australia and Asia Pacific. She has been recognized as a Member of the Order of Australia for her services to oncology.

Heather White, DrPH

Dr. Heather White is a global health specialist with over 20 years of experience in non-communicable diseases, family planning, HIV, and cervical cancer prevention. She serves as the executive director at TogetHER for Health, a global advocacy organization that collaborates with global partners to underscore the need for innovation and financing to support cervical cancer elimination. Heather holds a doctorate in public health from the University of Alabama at Birmingham.

Kara Magsanoc-Alikpala

Kara Magsanoc-Alikpala is a cancer patient advocate, a broadcast journalist and a documentary filmmaker based in the Philippines. She is the founding president of the ICANSERVE Foundation, an NGO that partners with cities to institutionalize breast cancer control programs. She is also the Vice President of the Cancer Coalition of the Philippines, the prime mover behind the passage in 2019 of the National Integrated Cancer Control Act. Alikpala is co-author of the study “Patient Centricity In Cancer Care” published by the Frontiers in Pharmacology. She is a patient advisory board member of the Lancet Commission on Women and Cancer, a Founding Member of the Board of Trustees of the Philippine Alliance of Patient Organizations, an Independent Board Member of Zodiac Health Ventures, Inc., and a member of the Multi Governance Board of Jose Reyes Memorial Medical Center. She co-founded the video production company Storytellers International Inc. She is a contributing producer for CNN International and ARD German Radio. She is the President of the Filipino Documentary Society. She has been a member of the jury for The Emmy Awards

Dr. PhuongThao Le

Dr. PhuongThao Le is assistant professor of community health sciences at Boston University School of Public Health. Her research focuses on developing, implementing, and evaluating evidence-based mental health programs for marginalized populations globally. She has conducted studies on human trafficking, individuals with serious mental illness, and mental health among cancer patients. Dr. Le is currently PI of a Fogarty/NIH-funded study to adapt and pilot a stress management intervention among breast and gynecologic cancer patients in Viet Nam.

Ms. Bui Thi Oanh

Ms. Oanh is a Pharmacist and Master of Public Health, working as clinical researcher and coordinator in Cancer Research and Clinical Trials Center at the National Cancer Institute in Vietnam. More recently, she is a final year PhD student at the Universtiy of Sorbonne Paris Nord on molecular biology in cancer. She was also involved in projects focusing on breast cancer management in a province in Vietnam sponsored by the Novartis. Her area of interest is clinical research, early cancer screening programs to prevent cancer in Vietnam.

Prof. NIRMALA BHOO PATHY

Nirmala Bhoo-Pathy is a Professor of Epidemiology in the Department of Social and Preventive Medicine, Faculty of Medicine, Universiti Malaya, and practices as a public health physician at Universiti Malaya Medical Centre, Malaysia. She is also a visiting scholar at Queen’s University Belfast, United Kingdom since 2014. Dr. Bhoo Pathy’s career is focused on optimizing life after cancer in resource-limited settings through research and advocacy. She is particularly interested in the state of cancer control in low- and middle-income countries and enhancing treatment outcomes and patient-centered outcomes in these settings. Notably, Dr. Bhoo Pathy was the principal investigator of phase III of the ASEAN CosTs In Oncology (ACTION) study, comprising close to 10,000 cancer patients from eight low-and middle-income member countries of the Association of South East Asian Nations (ASEAN). The study has provided country-specific evidence for Southeast Asian nations to prioritize policies and develop local solutions to reduce the financial loss and premature deaths associated with cancer. Dr. Bhoo-Pathy currently serves in two Lancet Commissions: the Lancet Commission on Women and Cancer and the Lancet Commission on Cancer and Health Systems. Besides her involvement in these commissions, she is a member of the Covid-19 and Cancer Taskforce, a globally representative group of cancer leaders who are gravely concerned that decisions made under the duress of the pandemic will have momentous consequences for cancer mortality for years to come https://covidcancertaskforce.org/ As the founder and scientific lead of a solution-oriented research group ‘Well with Cancer in Malaysia (WeCan@MY) https://spm.um.edu.my/wecan@my/ in the Department of Social and Preventive Medicine, Nirmala Bhoo-Pathy currently oversees a wide range of studies on cancer care, cancer control, and cancer policy, locally and also globally; These projects range from qualitative inquiries, to questionnaire development, epidemiological studies, implementation science, and health systems research. Nirmala Bhoo Pathy graduated as a medical doctor from Universiti Malaya, Malaysia in 2001. Following completion of her master’s degree in Public Health with distinction in 2008, she was awarded a fellowship by the European Commission, under which she completed a master’s degree in clinical epidemiology with cum laude, followed by a Ph.D. (cancer epidemiology) from the University of Utrecht, Netherlands in 2011.

Dr. Partha Basu

Dr. Partha Basu is Head of the Early Detection, Prevention, and Infections Branch at the International Agency for Research on Cancer (IARC/WHO), France. Dr. Basu did his MD in Obstetrics and Gynecology, post-doctoral fellowship in Gynecological Oncology, and PhD in Clinical Oncology. He has been awarded the honorary FRCOG by the Royal College of Ob & Gyn, UK recently. Before joining IARC in 2015, he was head of the Department of Gynecological Oncology at the National Cancer Institute in India. Dr. Basu is well known for his research that has informed several guidelines and recommendations from the WHO. His research has been instrumental to recent events that will promote equity in preventing cervical cancer, such as the WHO concluding that a single dose of HPV vaccine delivers solid protection, authorities recommending marketing authorization for a new low-cost HPV vaccine in India, and WHO recommending a simple and affordable technology (thermal ablation) for treatment of cervical precancers. Evidence generated from his study on the long-term impact of triennial screening for breast cancer with clinical breast examination (CBE) will be very valuable for the WHO’s global breast cancer initiative. Dr. Basu has been supporting countries across the globe to implement cancer screening programs with equity and quality through the project named Cancer Screening in Five Continents (CanScreen5). He is leading implementation research projects aiming at improving cancer early detection in socio-economically disadvantaged populations in three countries in Europe and in India. He has significantly contributed to building capacity in delivering quality assured cervical and breast cancer early detection services in several low and middle-income countries. Dr. Basu has 236 publications in peer-reviewed journals with more than 6000 citations.

Ms. Ranjit Kaur Pritam Singh

● Breast cancer survivor since 1998 ● Basic qualification in Physiotherapy, and a Master of Science degree in Community Disability Studies (University College London, UK) ● Technical Committee Lead on Community and Patient Access, City Cancer Challenge Greater Petaling, Malaysia ● Patient Advocate and Consultant to Breast Cancer Welfare Association Malaysia ● Committee Member, Together Against Cancer Association Malaysia (TAC) ● Member of Board of Visitors, KPJ, Damansara Specialist Hospital, Malaysia ● Board Member, Reach to Recovery International ● Board Member, Advanced Breast Cancer Global Alliance ● Peer Reviewer for the Package of Interventions for Rehabilitation for Cancer (mainly LMICs) led by the World Health Organisation ● Member of the Board of Visitors Hospital KPJ, TTDI, Malaysia Ranjit conducts training in Reach to Recovery peer support and peer navigation in cancer care, Doctor-Patient communication skills, and health literacy topics for medical students and moderators for international forums. She is a consultant and trainer for several regional and global cancer-related groups. Awards: Outstanding UICC Volunteer Award (2004) Theresa Lasser Award conferred by Reach to Recovery International (2011).

Dr. Kim-Son Nguyen

Dr. Kim-Son Nguyen is an adjunct clinical assistant professor of medicine at Stanford University School of Medicine and Stanford Cancer Institute. He is also a staff medical oncologist at Sutter Health. Dr. Nguyen obtained his Bachelor of Arts from Harvard College and his Doctor of Medicine from Harvard Medical School before completing internal medicine residency at Harvard and hematology-oncology fellowship at Stanford

ASSOC. PROF. Roselle B. De Guzman, MD, FASCO

Dr. De Guzman is a medical oncologist particularly interested in global oncology, access to quality care, and health care delivery in resource-limited settings. She has focused interests on the most common cancers in Southeast Asia including breast, head and neck, and thoracic malignancies. She has been committed to further exploring and advancing her work and interests through participation in international programs, educational opportunities, research collaborations, and professional development. Dr. De Guzman is a member and fellow of the American Society of Clinical Oncology (ASCO). She served as immediate past chair of the Asia Pacific Regional Council of ASCO that is assisting the Society in advancing its mission in Asia Pacific. Dr. De Guzman has been actively involved in ASCO’s international programs focusing on improving the multidisciplinary care and access of patients to quality care, especially in low- and middle-income countries. Dr. de Guzman takes part in organizing and conducting multidisciplinary cancer management courses (MCMC) focusing on the common cancers in Asia including breast cancer. She was actively involved as a member of the organizing committee of the ASCO MCMC program held in the Philippines, as a faculty in MCMC Myanmar, and as a course director at MCMC Greater Petaling, Malaysia. She began to be involved in supporting patient advocates for breast cancer. She served as one of the advisors to the scientific program of the 2022 Southeast Asia Breast Cancer Symposium successfully and jointly organized by the Global Focus on Cancer and the ICanServe Foundation, Inc. Dr. De Guzman was a graduate of ASCO’s Leadership Development Program (LDP) in 2015. As a member volunteer of the Society, she served in other leadership positions including chair of the Multidisciplinary Cancer Management Course Working Group and the International Development and Education Award (IDEA) Working Group. As a long-standing member of ASCO, she has served on various committees and advisory groups including the International Affairs, the Annual Meeting Scientific Committee, the Plenary Series Committee, the program committee for the LDP – Asia Pacific, and Resource-Stratified Practice Guideline advisory group. She is the first oncologist in the Philippines to receive the ASCO IDEA, an award that is given to deserving young oncologists from low- and middle-income countries. Dr. De Guzman participates in the professional development of cancer specialists in the global oncology community through the LDP and ASCO’s Women Networking Center. She has written about concerning issues in global oncology focusing on Asia Pacific. These include the vulnerability of patients due to environmental challenges including climate change and natural disasters, the dual challenge of cancer and CoVid-19 in the region, and healthcare delivery in resource-limited settings.

Prof. Winnie K.W. SO

Prof. Winnie So is a Professor of the Nethersole School of Nursing, The Chinese University of Hong Kong. She is also the President of International Society of Nurses in Cancer Care and the Past-President of Asian Oncology Nursing Society. As a scholar and scientist in cancer care, Prof. So’s research substantively influenced knowledge generation which manifested as evidence-based intervention for reducing cancer burden and enhancing quality cancer care. She has obtained more than HK$20 million to support her research and knowledge transfer projects and has published 200 papers in international peer reviewed journals. The impact of her research is far-reaching and cited in nursing and health related journals.

Ms. Nguyen Huong Giang

I am a Medical Doctor of Preventive Medicine and Master of Public Health, currently the Head of the Cancer Epidemiology Department at the National Cancer Institute in Vietnam. My area of expertise lies in cancer epidemiology, specifically in cancer registry management and cancer control policy. In addition to my work in Vietnam, I am also an active participant in the Asian National Cancer Centers Alliance (ANCCA), where I collaborate with other experts in the region. As a coordinator for cancer registry in the National Cancer Control Program, I am committed to contributing to cancer research, publication, and cancer control efforts in Vietnam.

Do Tuyet Mai, MD, MSc

Dr.Do Tuyet Mai graduated from Hanoi Medical University with a good degree in the General Practitioner Program. She completed the Psychiatric Residency Program with an excellent degree and got the Master of Medicine at Hanoi Medical University. She was trained in Australia with the Howard Cooper Fellowship by The Royal Australian and New Zealand College of Psychiatrists (RANZCP) in 2019. Dr Mai also participated in the Course on Leadership and Professional Development for young psychiatrists conducted by the Indonesian Psychiatric Association collaborating with the Lundbeck International Institute. Dr. Mai has had more than 5 years of experience in consulting and treating patients with psychiatric problems, training for medical staffs about mental health care in Hanoi, Vietnam. More recently, she is expanding her interest into psycho-oncology, and now she is working as a psychiatrist and psycho-oncologist at Vietnam National Cancer Hospital. Dr Mai plans to build the psychosocial programs to support the cancer patients, as well as work on the integration of psychosocial care into routine cancer care in Vietnam.

Ms. Kwok Yuk Lai Carman

Carman has professional interests focused on palliative and end-of-life care. She received palliative care nursing specialty training and completed a doctoral nursing degree in 2018 from the Chinese University of Hong Kong. Currently, Carman is a palliative care nurse specialist working in a hospice center in Hong Kong.

PHAN CANH DUY MD, PhD

Professor Marsha Rosner

Marsha Rich Rosner currently works at the Ben May Department for Cancer Research, University of Chicago. Marsha does research in Cell Biology, Molecular Biology and Cancer Research. Marsha Rosner’s lab focuses on the signaling mechanism that leads to the generation of tumor cells and their progression to metastatic disease. Her research has led to a way to treat resistant breast cancers by repurposing two older drugs. Studies by Rosner and her team have led to potential therapeutic treatments that could extend beyond breast cancer to others, including lung, kidney, uterus and prostate cancers and leukemia. Rosner started with a finding that provided insights into how cells generate energy and metabolize foods, and that led to novel ideas about how to treat resistant cancers. Rosner employs a diverse group of colleagues from around the world, from undergraduates to postdoctoral fellows. She also is founder and first chair of the University of Chicago Committee on Cancer Biology.

CHAU THI HOA

Mrs. Chau Thi Hoa graduated from Danang Medical College in 1983 with a major in Nursing. She then graduated from Hue University of Medicine and Pharmacy with a Bachelor of Nursing in 2002 and nursing specialist 1 degree in 2011. She attended the Palliative Care course at Memorial Sloan Kettering Cancer Center, NY, USA in 2002 and a course of Cancer Research at Chestertown Mariland, USA in 2015. Regarding her career history, from 1987-2002, she worked in Intensive Care Unit of Hue Central Hospital. From 2003 to June 2015, she was the head nurse of Department Oncology Hue Cetral Hospital. She has worked at the Oncology Center after retiring in July 2015 until now. She has published 12 articles and 1 book from 2006 to 2023. She is currently a member of many associations such as: Hue Breast Cancer Society, Thua Thien Hue Cancer Society, Vietnam Cancer Society, executive committee of Vietnam Palliative Health Care Society and Asia Pacific Hospice Palliative Care Network (APHN).

Vu Thu Thao

After graduating from university with a major in Social Work, she continued her studies. She completed a Master's program specializing in Public Health at the National Cancer Center in South Korea. Currently, Vu Thu Thao holds the position of Deputy Head of the International Cooperation - Scientific Research Department at Vietnam National Cancer Hospital (K Hospital). In this role, she participates in and coordinates several projects to enhance the cancer-fighting capabilities for various types of cancer such as breast cancer, lung cancer, and childhood cancer. This demonstrates the breadth and depth of her dedication and efforts in assisting individuals afflicted with different forms of cancer. With her knowledge in social work and public health, Vu Thu Thao can make significant contributions to building support and care programs for cancer patients, as well as raising awareness and preventing these diseases within the community.

Dr. Kardinah

Education / Training 1985 General Physician, University of Indonesia 1993 Radiologist, University of Indonesia 1999 2003 UICC Fellow (Netherlands) 2012 Consultant Breast and Gynecology imaging Working experience 2006-2017 Head of Radiology Department Dharmais Cancer Hospital 2018- now Head of Medical Committee National Cancer Center/Dharmais Cancer 2012-2020 Chairman of Indonesian Women Imaging Society Scientific activities 2014 – Kardinah. Anderson B, Duggan C, Ali I and Thomas D., Short report: Limited effectiveness of screening mammography in addition to clinical breast examination by trained nurse midwives in rural Jakarta, Indonesia. Int J Cancer 2014:134;1250-1255 2023 - Contributor in Global Breast Cancer Initiative Implementation Framework: Assessing, strengthening, and scaling up services for early detection and management of breast cancer

Assoc Prof. PHAM NGUYEN TUONG, MD

Dr Tuong graduated from Hue University of Medicine and Pharmacy, got PhD in Oncology at Hanoi Medical University Vietnam and then had training courses at Saint Luc Hospital (Belgium), AKH (Austria) and National Cancer Center Singapore. He has over 20 years of experience in cancer treatment, focusing on radiation therapy and palliative care. In addition, he also has participated in teaching programs at medical universities/schools in the central region of Vietnam, technology transfer programmes for provincial hospitals in two fields: radiation oncology and palliative care for cancer patients. Have published over 60 scientific articles in national and international peer-reviewed journals. Deputy Editor-in-Chief of Journal of Clinical Medicine, Hue Central Hospital. Dr Pham Nguyen Tuong was the principal investigator (Vietnamese site) of the scientific research project APPROACH (Asian Patient Perspectives Regarding Oncology Awareness, Care, and Health) conducted by LIEN Palliative Care Center, School of Medicine, National University Singapore. The research has been successfully completed. He is a member of the Executive Committee of the Vietnam Cancer Society, Vice President of the Vietnam Association of Palliative Medicine.